75 results
Page 2 of 4
8-K
EX-1.1
qvicrqe7gqpl7ozur
2 Feb 24
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-10.1
h1fuqksb
2 Feb 24
Entry into a Material Definitive Agreement
5:00pm
424B4
z3crdr au3ugb2ooe8iy
31 Jan 24
Prospectus supplement with pricing info
4:27pm
8-K
EX-10.1
vgjf lgjqcuypuy93l7
18 Sep 23
Submission of Matters to a Vote of Security Holders
7:51pm
424B4
xyxkv3a9dpcee 7gyf
2 Dec 22
Prospectus supplement with pricing info
5:40pm
8-K
EX-10.2
6zxfc0m0sp2 xuvrol
1 Dec 22
CNS Pharmaceuticals Announces Pricing of $6.0 Million Public Offering At a Premium to the Market Closing Price
5:19pm
8-K
EX-10.1
hi4cmu91qpj36zitdju
1 Dec 22
CNS Pharmaceuticals Announces Pricing of $6.0 Million Public Offering At a Premium to the Market Closing Price
5:19pm